Page last updated: 2024-10-22

anthralin and Carcinoma, Squamous Cell

anthralin has been researched along with Carcinoma, Squamous Cell in 1 studies

Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
La, E1
Muga, SJ1
Locniskar, MF1
Fischer, SM1

Other Studies

1 other study available for anthralin and Carcinoma, Squamous Cell

ArticleYear
Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    Molecular carcinogenesis, 1999, Volume: 24, Issue:4

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anthralin; Blotting, Northern; Blotting, Western; Carcino

1999